3.03 The National Lung Matrix Trial & the Major Flaw of the SPRINT Trial with Dr. Mark Friedberg
July 18, 2020
622
11
1.77%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Vinay Prasad Md Mph Episodes Around July 18, 2020
See what was published immediately before and after this episode.
1:09:29Now Playing3.03 The National Lung Matrix Trial & the Major Flaw of the SPRINT Trial with Dr. Mark Friedberg
YouTube Description
as posted by the channelThis week we discuss two major papers: The first was just recently released in Nature and it's titled "The National Lung Matrix Trial of personalized therapy in lung cancer". The second is a few years old, but exemplifies the importance of trial design. We discuss the second paper, titled "A Randomized Trial of Intensive versus Standard Blood-Pressure Control" and published in the New England Journal of Medicine with Dr. Mark Friedberg, a health policies and performance measurement researcher.
National Lung Matrix Trial: doi.org/10.1038/s41586-020-2481-8
SPRINT: doi.org/10.1056/NEJMoa1511939
Back us on Patreon! www.patreon.com/plenarysession
Vinay Prasad
HemeOnc Doctor & Associate Professor
Host of Plenary Session Podcast
Twitter @vprasadmdmph
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.